BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,776,120 | -78.9% | 1,292,425 | -74.5% | 0.01% | -76.6% |
| Q2 2023 | $230,734,748 | +51.4% | 5,064,415 | +34.8% | 0.05% | +42.4% |
| Q1 2023 | $152,354,392 | +17.3% | 3,756,272 | +47.4% | 0.03% | +10.0% |
| Q4 2022 | $129,915,598 | +116.8% | 2,548,864 | +129.1% | 0.03% | +130.8% |
| Q3 2022 | $59,928,000 | -37.2% | 1,112,651 | -25.2% | 0.01% | -48.0% |
| Q2 2022 | $95,494,000 | -20.6% | 1,486,755 | -4.1% | 0.02% | 0.0% |
| Q1 2022 | $120,195,000 | -47.5% | 1,550,097 | -41.8% | 0.02% | -45.7% |
| Q4 2021 | $228,733,000 | +19.9% | 2,664,645 | +12.3% | 0.05% | +17.9% |
| Q3 2021 | $190,777,000 | +112.8% | 2,371,958 | +113.0% | 0.04% | +85.7% |
| Q2 2021 | $89,636,000 | +55.3% | 1,113,494 | +62.7% | 0.02% | +50.0% |
| Q1 2021 | $57,714,000 | +69.6% | 684,300 | +61.3% | 0.01% | +55.6% |
| Q4 2020 | $34,033,000 | -60.5% | 424,141 | -60.4% | 0.01% | -62.5% |
| Q3 2020 | $86,222,000 | +77.1% | 1,072,142 | +89.7% | 0.02% | +33.3% |
| Q2 2020 | $48,674,000 | -86.8% | 565,308 | -87.5% | 0.02% | -89.1% |
| Q1 2020 | $367,498,000 | -22.5% | 4,526,386 | -20.1% | 0.16% | -19.9% |
| Q4 2019 | $473,917,000 | +363.4% | 5,667,500 | +384.7% | 0.21% | +329.2% |
| Q3 2019 | $102,274,000 | +9.3% | 1,169,248 | +2.3% | 0.05% | +9.1% |
| Q2 2019 | $93,579,000 | +452.8% | 1,142,602 | +448.8% | 0.04% | +388.9% |
| Q1 2019 | $16,929,000 | -26.0% | 208,200 | -40.1% | 0.01% | -30.8% |
| Q4 2018 | $22,883,000 | -50.7% | 347,667 | -42.2% | 0.01% | -35.0% |
| Q3 2018 | $46,376,000 | -81.1% | 601,588 | -81.9% | 0.02% | -83.5% |
| Q2 2018 | $245,177,000 | -20.8% | 3,320,394 | -30.2% | 0.12% | -28.0% |
| Q1 2018 | $309,380,000 | -11.7% | 4,756,758 | -12.3% | 0.17% | -21.1% |
| Q4 2017 | $350,536,000 | +211.2% | 5,422,896 | +202.1% | 0.21% | +144.8% |
| Q3 2017 | $112,642,000 | -9.1% | 1,795,093 | -12.3% | 0.09% | -17.1% |
| Q2 2017 | $123,985,000 | +104.6% | 2,047,980 | +75.3% | 0.10% | +87.5% |
| Q1 2017 | $60,598,000 | +11.8% | 1,168,486 | -4.4% | 0.06% | +1.8% |
| Q4 2016 | $54,199,000 | -82.8% | 1,222,363 | -81.5% | 0.06% | -82.6% |
| Q3 2016 | $315,357,000 | +49.2% | 6,625,115 | +41.8% | 0.32% | +34.9% |
| Q2 2016 | $211,295,000 | -1.5% | 4,672,588 | -10.5% | 0.24% | -13.3% |
| Q1 2016 | $214,533,000 | -25.5% | 5,222,320 | -30.8% | 0.27% | -13.7% |
| Q4 2015 | $287,970,000 | +500.5% | 7,548,364 | +417.1% | 0.31% | +582.6% |
| Q3 2015 | $47,953,000 | -61.5% | 1,459,754 | -18.0% | 0.05% | -57.4% |
| Q2 2015 | $124,547,000 | +21.5% | 1,781,011 | +19.0% | 0.11% | +11.3% |
| Q1 2015 | $102,511,000 | +373.8% | 1,496,506 | +406.9% | 0.10% | +361.9% |
| Q4 2014 | $21,638,000 | -0.9% | 295,228 | -3.0% | 0.02% | -8.7% |
| Q3 2014 | $21,835,000 | -70.4% | 304,240 | -70.1% | 0.02% | -72.6% |
| Q2 2014 | $73,668,000 | +190.5% | 1,018,924 | +195.6% | 0.08% | +180.0% |
| Q1 2014 | $25,361,000 | +49.5% | 344,675 | +41.3% | 0.03% | +36.4% |
| Q4 2013 | $16,966,000 | +110.2% | 243,941 | +98.6% | 0.02% | +83.3% |
| Q3 2013 | $8,070,000 | -88.2% | 122,842 | -87.5% | 0.01% | -89.7% |
| Q2 2013 | $68,172,000 | – | 984,147 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |